Onconetix Announces Exercise of Warrants for $1.11 Million Gross Proceeds

H.C. Wainwright & Co. is acting as the exclusive placement agent for the transaction. In consideration for the immediate exercise of the existing warrants for cash, the Company will issue new unregistered warrants to purchase up to an aggregate of an aggregate of 22,375,926 shares of common stock at an exercise price of $0.15 per share in a private placement pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended (the "1933 Act"). The shares of common stock issuable upon exercise of the new wa ...